These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16044660)

  • 1. Editorial overview: serotonergic agents in functional GI disorders: targeting the brain-gut axis.
    Wessinger S; Jones MP; Crowell MD
    Curr Opin Investig Drugs; 2005 Jul; 6(7):663-6. PubMed ID: 16044660
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
    Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ
    Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and its role in colonic function and in gastrointestinal disorders.
    Costedio MM; Hyman N; Mawe GM
    Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
    Gershon MD; Tack J
    Gastroenterology; 2007 Jan; 132(1):397-414. PubMed ID: 17241888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders.
    Sanger GJ; Lee K
    Nat Rev Drug Discov; 2008 Mar; 7(3):241-54. PubMed ID: 18309313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of functional bowel disorders: any light at the end of the tunnel?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):669-70. PubMed ID: 18835367
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.
    Grover M; Camilleri M
    J Gastroenterol; 2013 Feb; 48(2):177-81. PubMed ID: 23254779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.
    Mawe GM; Hoffman JM
    Nat Rev Gastroenterol Hepatol; 2013 Aug; 10(8):473-86. PubMed ID: 23797870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and GI clinical disorders.
    Spiller R
    Neuropharmacology; 2008 Nov; 55(6):1072-80. PubMed ID: 18687345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic receptors in therapeutic approaches to gastrointestinal disorders.
    Neal KB; Bornstein JC
    Curr Opin Pharmacol; 2006 Dec; 6(6):547-52. PubMed ID: 16973419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system and gut-brain signalling.
    Storr MA; Sharkey KA
    Curr Opin Pharmacol; 2007 Dec; 7(6):575-82. PubMed ID: 17904903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine.
    Smid SD
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1383-7. PubMed ID: 18671715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic receptors as future targets for treatment of functional GI disorders.
    Burnstock G
    Gut; 2008 Sep; 57(9):1193-4. PubMed ID: 18719131
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders.
    Mayer EA; Naliboff BD; Craig AD
    Gastroenterology; 2006 Dec; 131(6):1925-42. PubMed ID: 17188960
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.
    Mayer EA; Tillisch K; Bradesi S
    Aliment Pharmacol Ther; 2006 Sep; 24(6):919-33. PubMed ID: 16948804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids and the gastrointestinal tract.
    Massa F; Monory K
    J Endocrinol Invest; 2006; 29(3 Suppl):47-57. PubMed ID: 16751708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating symptoms into mechanisms: functional GI disorders.
    Collins SM
    Adv Physiol Educ; 2007 Dec; 31(4):329-31. PubMed ID: 18057404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin in the gastrointestinal tract.
    Camilleri M
    Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):53-9. PubMed ID: 19115522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence.
    Kuiken SD; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2005 Mar; 21(6):633-51. PubMed ID: 15771750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment functional GI disease: the complex pharmacology of serotonergic drugs.
    De Ponti F; Crema F
    Br J Clin Pharmacol; 2002 Dec; 54(6):680-1; author reply 681-2. PubMed ID: 12492621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.